Small Vessel Cerebrovascular Disease
15
6
7
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (15)
Small Vessel Disease and Cerebral Infarct Healing InErvation Via Limb Distant Adaptation
Evaluation of Small Vessel Disease by 3D-rotational Angiography
Targeting Neurovascular Coupling in Cognitive Decline Via Nitrate-Based Supplementation
Telecoached Exercise Intervention for Connectivity Enhancement in Small Vessel Disease (TELECONNECT-SVD)
Oxford Haemodynamic Adaptation to Reduce Pulsatility Trial
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases
Coronary Microvascular Angina Cardiac Magnetic Resonance Imaging (CorCMR) Trial
Remote Ischemic Conditioning With Novel Optical Sensor Feedback Device in Acute Ischemic Stroke
Hyperintense: Midlife Hypertension and the Brain
The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)
Prognosis of Cerebral Small Vessel Disease
Intensive Blood Pressure Control in Ischaemic Stroke Patients With Severe Cerebral Small Vessel Disease
Start or STop Anticoagulants Randomised Trial (SoSTART)
Development of a Global Scale Assessing Impairment in Cerebral Small Vessel Diseases